EE233 Cost-Effectiveness of Ravulizumab Compared with Eculizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in the Netherlands

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.481
https://www.valueinhealthjournal.com/article/S1098-3015(22)02685-7/fulltext
Title : EE233 Cost-Effectiveness of Ravulizumab Compared with Eculizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in the Netherlands
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02685-7&doi=10.1016/j.jval.2022.09.481
First page :
Section Title :
Open access? : No
Section Order : 12290
Categories :
Tags :
Regions :
ViH Article Tags :